Over the first quarter of 2024, Carmignac Absolute Return Europe realized a positive performance of +4.95%.
After a strong year-end rally in 2023, markets came into 2024 screening overbought. Subsequently a stronger than expected US inflation print in January, drove a sudden reversal of bond markets with yields quickly rising from the December lows, which in turn, catalysed a quick rotational correction in European equities with cyclicals giving back some of their Q4 gains and underperforming defensives by more than 5%.
From a macro standpoint the dominant theme through the quarter was the timing of Fed interest rate cuts being repriced, shifting from March to June and at time of writing even putting July in question. In Europe, by contrast CPI’ readings have continued to be more supportive to a cut with the first one anticipated to come in June. Despite US rate cuts being ‘pushed out’, market seems to be taking this in its stride as it is being accompanied by increasing evidence that the US economy remains robust and a number of the leading indicators including PMI’s and Zew survey (EU) are showing sequential improvement at the same time as inflation data although hotter than expected is still trending down. This backdrop has created a positive environment for equity markets which now increasingly looks to price a benign ‘Goldilocks ‘ soft landing scenario which has continued through Q1 and driven the market rally. Within Europe during Q1, cyclicals outperformed defensives with the best performing sectors being Autos, Technology, Banks and Industrials while the main laggards were Basic Resources, Utilities and Real Estate.
The fund produced a positive return of +4.95% net of fees and since taking over the management of the fund in September last year, we are pleased to report 6 consecutive months of positive investment returns, putting us well on track to achieve our long-term objectives (10-12% pa performance net of fees).
As we continue to gain evidence that our investment process is working well, we recently begun as per our plan to increase the size of the funds gross exposure by increasing position sizes across both our long and short positions. Our gross exposure has now gone up from around 100% to apr.135%. Our net exposure was gradually increased throughout the period to around the mid 20’s%, but it remains a moving target depending on how we navigate risk from one week, month to another. Our typical range for our adjusted net exposure during the period has been 20-30%.
At the stock level, with growing confidence in a more constructive backdrop to the market we continued to add to our positions in technology, consumer discretionary and banks. Within technology we have continued to build on the theme of AI beneficiaries. We’ve added to our existing semiconductor positions, including AI and more recently added new positions in manufacturers of processors and memory, essential for the operation of the AI models along with software beneficiaries.
In consumer discretionary we added to low-cost airlines where we believe the backdrop of short haul pricing is likely to continue to surprise the market to the upside. The EU short haul market continues to be very tight given the ongoing delays for new airplanes being delivered to airlines (Boeing’s issues). This continues to drive higher airfares, which in turns will give rise to further earnings upgrades against share prices which are still trading significantly below their pre Covid valuations. Similarly, we believe the stock market is pricing in an overly conservative outlook for Autos against their much too low valuations. Also, both these sectors are deep value which is a factor we want to add exposure to.
Profits were taken in some of our luxury goods names which have performed well and now face slowing growth with difficult year on year comparable. However, once we are through the H1 period, comps again get easier and we would look to add back exposure on the long side, possibly as soon as after / during the Q1 reporting season. Elsewhere we added to retail banks where we see opportunities in names with still too low valuations and with surplus capital that will be returned to shareholders. Across the industrial sectors we added to long cycle businesses with strong order books in areas such as Aerospace.
Whilst it has been very important to ensure that we got our long book stock selection right, it has been equally important to carefully manage our short stock portfolio in rising market and at a time of potential economic inflections, making sudden burst of short squeezes potentially very costly. We have reduced or covered a number of cyclical shorts positions to protect the portfolio against unnecessary losses but will certainly look to revisit these later in the year.
Within the portfolio the largest positive returns YTD have come from technology, banks, consumer discretionary, industrials and healthcare. The main detractors at the sector level were Utilities, Real Estate and Staples with small losses.
Winners:
Losers:
As stated with our monthly update last week, the early part of April is expected to be relatively quiet from a corporate news flow stand point, and instead most of the focus well be on the macro, political developments (middle east, and particularly any potential impact on oil prices) & various Fed speaker commentary. The ongoing debate on rates and inflation expectations continue to dominate with macro data being mixed. Indeed, with the most recent soft macro data having surprised to the upside, Fed rate cut expectations continues to be pushed out. Therefore, this week’s CPI print will probably mark the most important data point for the Fed YTD. Should we yet again get a ‘hotter’ inflation print for March, the risk is that the market will quickly push out Fed cuts even further and fueling the debate to whether we get any cuts at all this year?
But very soon the attention will swiftly again shift back to corporate earnings and the key question most investors will be asking is whether momentum can continue to deliver. We have already seen some stalling of Technology and the Nasdaq itself losing relative performance over the last month, and the question is, if this is just an ‘air pocket’ or the start of new leadership emerging and a more sustainable broadening out of the market? The argument for the latter would be that the macro data (PMI’s, employment etc.) continues to improve, with the economies around the world slowly improving.
However, even if the top-down macro picture is giving us ‘hints’ of improving economic activity, which in turn is beginning to drive relative performance of value and cyclicals (especially in EU), we now need to closely monitor whether corporate earnings / forward expectations commentary of those companies can ‘accompany’ and support that performance? Have these sectors ‘travelled too far too soon’, without giving us the earnings revisions the market might now be pricing? In our view, the Banks, Chemicals & Autos are likely to deliver enough in Q1 to support ongoing performance and we continue to be weighted accordingly. In addition, all eyes are now firmly back on China. China’s PMIs have also started to show signs of improvements.
Therefore, taking all this into account, especially considering how most global investors are still very narrowly positioned to a few selective sectors, (Tech, Quality growth etc.) we think it is sensible to start selectively broadening out our exposure to a more balanced and ‘bar-belled’ portfolio. In part, as our regular readers will know, we do already have decent exposure to Value & Cyclicality in our book (which is already contributing to our YTD performance, through Banks, Cyclical chemicals, Airlines, and deep value Autos. And to us, the question is now whether we continue to add to these sectors? The decision to do that will be dependent on the upcoming macro news unfolding on inflation expectations and above all, Q1 corporate earnings. In addition, as per usual during Q2 we will be spending quite a bit of time meeting with corporates at various upcoming conferences. Usually these meetings prove to be very timely and valuable in terms to how to balance the risk of the portfolio and individual stock positions into the usually tricker to navigate months during the summer. Expect us to comment more on this In upcoming monthly letters.
However, not to confuse any of our readers, we still very much believe in the structural stories within Tech, AI & semis in particular, which continues to make up our single largest core Long exposures. In addition to AI linked stock positions, we have continued to increase our longs in memory names. We firmly believe that the amount of compute required, not only into the cyclical upturn in the sector, but above all due to the structural drivers will be enormous. As such, even if several of these stocks have done v well YTD, we continue to see material upside from here. And we believe that the news flow will not only be supportive, but that earnings upgrades will accelerate. We continue to believe that the current environment provides a fertile hunting ground for long short investors.
*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.
Carmignac Absolute Return Europe | 2.5 | -8.0 | 8.9 | 14.6 | 4.4 | -1.3 | 5.2 | 12.6 | -6.4 | 0.0 |
Carmignac Absolute Return Europe | - 1.1 % | + 3.9 % | + 3.2 % |
Source: Carmignac at 30 Sep 2024.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.
This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.
The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.
In France, Luxembourg, Sweden: The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital. The Funds’ prospectus, KIDs, NAV and annual reports are available at www.carmignac.com, or upon request to the Management.
In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.co.uk, or upon request to the Management Company, or for the French Funds, at the offices of the Facilities Agent at BNP PARIBAS SECURITIES SERVICES, operating through its branch in London: 55 Moorgate, London EC2R. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.
In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.
The Management Company can cease promotion in your country anytime.
Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.